Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cerebral arteriopathy and its role in persistent post-COVID headache and brain fog: a quantitative study.

European archives of psychiatry and clinical neuroscience·2026

Same author

Blood-brain barrier integrity and brain entropy in reversible cerebral vasoconstriction syndrome.

The journal of headache and pain·2026

Same author

Mapping human glymphatic compartments and putative meningeal border pathways in diseased models.

Brain : a journal of neurology·2026

Same author

Sex differences modulate olfactory bulb volume-function relationships but not olfactory training-induced plasticity.

Brain structure & function·2026

Same author

Highlights.

Journal of the Chinese Medical Association : JCMA·2026

Same author

Distal embolic protection and procedural strategy in percutaneous transluminal angioplasty and stenting of very severe carotid stenosis.

Journal of neurointerventional surgery·2026

Same journal

Altered hypothalamic metabolism in chronic cluster headaches patients measured with <sup>1</sup>H-MRS at ultra-high magnetic field.

The journal of headache and pain·2026

Same journal

Predictive factors of response to anti-CGRP pathway drugs in people with multiple sclerosis.

The journal of headache and pain·2026

Same journal

Trigeminovascular calcitonin gene-related peptide release and peripheral vascular responses in a mouse model of accelerated aging: Implications for migraine.

The journal of headache and pain·2026

Same journal

Cerebrovascular reactivity in migraine: a breath-hold BOLD fMRI study.

The journal of headache and pain·2026

Same journal

Profile of migraine patients in Middle East and North Africa (MENA) region: a multi-center study.

The journal of headache and pain·2026

Same journal

CXCL10 knockdown attenuates vestibular migraine in rats by inhibiting PI3K-mediated neuroinflammation and central sensitization.

The journal of headache and pain·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 11, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

Post-reversible cerebral vasoconstriction syndrome headache.

Yu-Hsiang Ling^1,2, Yen-Feng Wang^1,2, Jiing-Feng Lirng^2,3

¹Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.

The Journal of Headache and Pain

|March 26, 2021

Summary

This summary is machine-generated.

Chronic headache, or post-reversible cerebral vasoconstriction syndrome (RCVS) headache, affects nearly half of patients and is linked to anxiety and prior migraines. Recovery often occurs within a year.

Keywords:

Chronic headache Prognosis Prospective Thunderclap headache Vasospasm

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

Related Experiment Videos

Last Updated: Nov 11, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Continuous IV Infusion is the Choice Treatment Route for Arginine-vasopressin Receptor Blocker Conivaptan in Mice to Study Stroke-evoked Brain Edema

Published on: September 1, 2016

Area of Science:

Neurology
Headache Medicine
Neuroscience

Background:

Reversible cerebral vasoconstriction syndrome (RCVS) can lead to persistent chronic headaches post-remission.
Understanding the long-term impact of RCVS on headache is crucial for patient management.

Purpose of the Study:

To determine the prevalence, characteristics, and risk factors of chronic headache after RCVS.
To assess the impact of post-RCVS headache on disability and recovery timelines.

Main Methods:

Prospective study of 134 RCVS patients, assessing demographics and psychological distress (Hospital Anxiety and Depression scale).
Evaluation of post-RCVS headache at 3 months, including manifestations and disability (MIDAS scores).

Main Results:

Nearly half (48.8%) of patients developed post-RCVS headache, often with migrainous features.
Higher anxiety levels and a history of migraine were significant risk factors.
Eleven percent of patients experienced moderate-to-severe disability; 50% recovery estimated around 389 days.

Conclusions:

Post-RCVS headache is a common and potentially disabling condition.
Anxiety and migraine history are key predictors for developing post-RCVS headache.
Most patients experience recovery within approximately one year.